Robin L Jones Selected Research

Soft Tissue Neoplasms

2/2016	Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.
1/2016	Epithelioid Sarcoma: Diagnostic Features and Genetics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robin L Jones Research Topics

Disease

110	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 07/2007
92	Neoplasms (Cancer) 03/2024 - 07/2004
24	Liposarcoma 01/2023 - 12/2005
22	Leiomyosarcoma 10/2023 - 12/2011
21	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2024 - 05/2013
21	Breast Neoplasms (Breast Cancer) 10/2019 - 07/2004
16	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2007
14	Disease Progression 01/2024 - 03/2016
13	Synovial Sarcoma (Synovioma) 01/2022 - 05/2011
11	Cardiotoxicity 10/2022 - 07/2004
9	Hemangiosarcoma (Angiosarcoma) 05/2023 - 10/2012
9	Testicular Neoplasms (Testicular Cancer) 01/2022 - 01/2011
8	Myxoid Liposarcoma 11/2022 - 12/2005
7	Fatigue 11/2022 - 01/2018
6	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 05/2010
5	Osteosarcoma (Osteogenic Sarcoma) 05/2023 - 05/2015
5	Clear Cell Sarcoma 01/2023 - 09/2011
5	Nausea 01/2022 - 07/2016
5	Anemia 01/2022 - 01/2017
5	Aggressive Fibromatosis (Desmoid) 12/2020 - 11/2009
4	Carcinogenesis 01/2020 - 01/2007
3	Diarrhea 01/2022 - 10/2020
3	Vomiting 01/2022 - 07/2016
3	Carcinoma (Carcinomatosis) 12/2019 - 09/2007
3	Neutropenia 01/2018 - 07/2016
3	Febrile Neutropenia 01/2017 - 07/2016
2	Epithelioid Hemangioendothelioma 01/2024 - 01/2021
2	Constipation 10/2023 - 10/2020
2	Alopecia (Baldness) 12/2022 - 10/2020
2	Leiomyoma (Uterine Fibroids) 06/2022 - 11/2016
2	Hypertension (High Blood Pressure) 01/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2022 - 05/2018
2	Rhabdomyosarcoma 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 03/2021 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2019
2	Hemorrhage 01/2021 - 10/2012
2	Myocarditis (Carditis) 01/2020 - 11/2006
2	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2017
2	Sepsis (Septicemia) 01/2020 - 01/2017
2	Leukopenia 01/2018 - 01/2017
2	Chondrosarcoma 08/2017 - 01/2012

Drug/Important Bio-Agent (IBA)

33	AnthracyclinesIBA 11/2022 - 07/2004
24	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 05/2011
15	TrabectedinIBA 03/2022 - 07/2007
13	ripretinibIBA 02/2024 - 01/2020
12	Tyrosine Kinase InhibitorsIBA 02/2024 - 01/2016
11	olaratumabIBA 03/2024 - 07/2016
10	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2008
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2006
10	AntigensIBA 01/2022 - 01/2011
10	pazopanib FDA Link 01/2022 - 01/2013
8	Imatinib Mesylate (Gleevec)FDA Link 01/2024 - 01/2013
8	Gemcitabine FDA Link 10/2023 - 01/2015
7	Phosphotransferases (Kinase)IBA 07/2022 - 02/2013
7	Ifosfamide FDA LinkGeneric 01/2018 - 05/2011
6	VaccinesIBA 11/2022 - 09/2012
6	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 03/2016
6	Monoclonal AntibodiesIBA 01/2019 - 07/2006
5	avapritinibIBA 11/2023 - 08/2020
5	eribulin FDA Link 01/2022 - 01/2017
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021 - 01/2017
5	regorafenibIBA 10/2021 - 05/2015
4	Sunitinib (Sutent)FDA Link 01/2024 - 12/2022
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2023 - 09/2017
4	Docetaxel (Taxotere)FDA Link 10/2023 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2019
4	Immune Checkpoint InhibitorsIBA 02/2022 - 05/2018
4	liposomal doxorubicin (Doxil)FDA Link 01/2021 - 09/2004
4	ParaffinIBA 01/2021 - 07/2008
4	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021 - 11/2006
3	RNA (Ribonucleic Acid)IBA 03/2024 - 06/2019
3	Sirolimus (Rapamycin)FDA Link 01/2024 - 01/2014
3	Formaldehyde (Formol)FDA Link 01/2021 - 07/2008
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2021
2	AntibodiesIBA 11/2022 - 01/2022
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2022 - 12/2007
2	tazemetostatIBA 01/2022 - 11/2020
2	Cancer VaccinesIBA 01/2022 - 12/2018
2	selinexorIBA 01/2022 - 08/2021
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 01/2012
2	CytokinesIBA 01/2022 - 01/2022
2	Neutralizing AntibodiesIBA 12/2021 - 12/2021
2	Alkylating AgentsIBA 01/2021 - 02/2015
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 11/2019
2	AlkaloidsIBA 01/2020 - 02/2014
2	ProdrugsIBA 05/2019 - 01/2017
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2014
2	Angiogenesis InhibitorsIBA 08/2017 - 01/2013

Therapy/Procedure

73	Therapeutics 02/2024 - 11/2006
60	Drug Therapy (Chemotherapy) 05/2023 - 02/2003
16	Neoadjuvant Therapy 01/2022 - 10/2006
11	Immunotherapy 02/2022 - 01/2011
10	Radiotherapy 10/2023 - 11/2006
4	Adjuvant Chemotherapy 01/2022 - 06/2008
3	Aftercare (After-Treatment) 11/2023 - 12/2022
2	Radiofrequency Ablation 10/2023 - 05/2013
2	Metastasectomy 11/2022 - 12/2020
2	Precision Medicine 03/2021 - 01/2021
2	Combination Drug Therapy (Combination Chemotherapy) 12/2020 - 01/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2018 - 05/2018